chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain, Pyrexia, SARS-CoV-2 test
Clinical narrative: extreme fatigue; intense headaches that would not go away with medication; chest pain; body aches severe to the point every part of my body was in pain; shoulder and neck pain; shoulder and neck pain; chills; sweats; fever; nausea; stomach pain; low back pain; non stop diarrhea after anything I ate or drank; very dizzy almost like motion sickness and higher blood pressure; motion sickness; higher blood pressure; This is a spontaneous report from a contactable consumer (patient). A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in the right arm on 31Mar2021 (at the age of 48 years old) (Lot Number: EP6955) as dose 2, single for COVID-19 immunisation. Medical history included hypothyroidism and hormone replacement therapy. The patient was not pregnant at the time of the events. Concomitant medications included thyroid taken for an unspecified indication, start and stop date were not reported and vitamins nos (DAILY VITAMINS) taken for an unspecified indication, start and stop date were not reported.  The patient previously took Compazine and experienced drug allergy. The patient also previously took Crestor (low dose crestor 2.5 mg). The patient previously took the first dose of BNT162B2 on 10Mar2021 (Lot Number: EN 6199) for COVID-19 immunisation and experienced extreme fatigue, headaches, chest pain, dizziness, chills, sweats, fever, body aches, and nausea. The patient did not have COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Daily vitamins, BHR hormone replacement, and thyroid were received within 2 weeks of vaccination. The patient had been tested for COVID-19 post-vaccination. On 31Mar2021 at 19:00, the patient experienced extreme fatigue, intense headaches that would not go away with medication, chest pain, body aches severe to the point every part of my body was in pain, shoulder and neck pain, chills, sweats, fever, nausea, stomach pain, low back pain, non stop diarrhea after anything I ate or drank, very dizzy almost like motion sickness and higher blood pressure. Treatment was received for the events. Events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included blood pressure measurement: higher blood pressure on 31Mar2021, SARS-CoV-2 test: negative on 19Mar2021 and SARS-CoV-2 test: negative on 09Apr2021. The outcome of the events was not recovered.   No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Headache, Tinnitus
Clinical narrative: Extreme fatigue; chills; arm pain; Tinnitus started 3/25/21 and continues to this day, 4/23/21; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the arm left on 24Mar2021 at 18:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included tamoxifen (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. On 25Mar2021 at 10:00, the patient experienced extreme fatigue, chills, arm pain, and tinnitus. The events resulted in a doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the adverse events included treatment as washed-out ears on office visit (OV) with primary care physician (PCP) on 02Apr2021. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme fatigue, chills, arm pain and tinnitus were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Pain in extremity, Tinnitus
Clinical narrative: Extreme fatigue; chills; arm pain; Tinnitus started 3/25/21 and continues to this day, 4/23/21; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the arm left on 24Mar2021 at 18:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included tamoxifen (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. On 25Mar2021 at 10:00, the patient experienced extreme fatigue, chills, arm pain, and tinnitus. The events resulted in a doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the adverse events included treatment as washed-out ears on office visit (OV) with primary care physician (PCP) on 02Apr2021. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme fatigue, chills, arm pain and tinnitus were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood urine present, Platelet count, Urine analysis
Clinical narrative: One episode of gross hematuria; This is a spontaneous report from a contactable physician. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an intramuscular route of administration on 12Apr2021 at 13:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, migraines, urinary incontinence and vasomotor symptoms from menopause. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included oxybutynin hydrochloride (DITROPAN XL), acetylsalicylic acid (ASPIRIN), atorvastatin calcium (LIPITOR), sumatriptan (IMITREX) for headache, amlodipine besilate (NORVASC), hydroxychloroquine sulfate (PLAQUENIL), omeprazole (PRILOSEC), hydrochlorothiazide (HYDRODIURIL) and venlafaxine hydrochloride (EFFEXOR XR); for an unknown indication, from an unknown date and unknown if ongoing.  It was unknown if the patient did receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 09:00, the patient experienced one episode of gross hematuria. The event resulted in emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event one episode of gross hematuria was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Haematuria
Clinical narrative: One episode of gross hematuria; This is a spontaneous report from a contactable physician. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an intramuscular route of administration on 12Apr2021 at 13:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, migraines, urinary incontinence and vasomotor symptoms from menopause. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included oxybutynin hydrochloride (DITROPAN XL), acetylsalicylic acid (ASPIRIN), atorvastatin calcium (LIPITOR), sumatriptan (IMITREX) for headache, amlodipine besilate (NORVASC), hydroxychloroquine sulfate (PLAQUENIL), omeprazole (PRILOSEC), hydrochlorothiazide (HYDRODIURIL) and venlafaxine hydrochloride (EFFEXOR XR); for an unknown indication, from an unknown date and unknown if ongoing.  It was unknown if the patient did receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 09:00, the patient experienced one episode of gross hematuria. The event resulted in emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event one episode of gross hematuria was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Immediate post-injection reaction, Joint range of motion decreased, Neck pain, Pain in extremity
Clinical narrative: Violently ill; weakened on left side of body mostly from left hip down but now also shoulder; Weekends on left side of body mostly from left hip down but now also shoulder; Feeling extreme disorientation; Extremely scary; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the right arm on 16Apr2021 at 09:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history (reported as perfectly healthy). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any other medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the right arm on 26Mar2021 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 21:00, 12 hours after vaccination, the patient experienced violently ill and could not get out of bed for 2 days and got better. On an unknown date in Apr2021 (also reported as week later), the patient experienced weakened on left side of body mostly from left hip down but now also shoulder, last night in the middle of the night, the patient woke up feeling extreme disorientation almost like she was in bed but was going to fall. The patient got out of bed crawled in all fours trying to get himself settled. The patient was able to get out of it slightly. It was extremely scary now patient felt the same left side weakness and nausea overall not feeling well at all. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events violently ill, weakened on left side of body mostly from left hip down but now also shoulder, extreme disorientation, scary and nausea was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthropathy, Disorientation, Malaise, Muscular weakness, Nausea
Clinical narrative: Violently ill; weakened on left side of body mostly from left hip down but now also shoulder; Weekends on left side of body mostly from left hip down but now also shoulder; Feeling extreme disorientation; Extremely scary; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the right arm on 16Apr2021 at 09:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history (reported as perfectly healthy). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any other medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the right arm on 26Mar2021 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 21:00, 12 hours after vaccination, the patient experienced violently ill and could not get out of bed for 2 days and got better. On an unknown date in Apr2021 (also reported as week later), the patient experienced weakened on left side of body mostly from left hip down but now also shoulder, last night in the middle of the night, the patient woke up feeling extreme disorientation almost like she was in bed but was going to fall. The patient got out of bed crawled in all fours trying to get himself settled. The patient was able to get out of it slightly. It was extremely scary now patient felt the same left side weakness and nausea overall not feeling well at all. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events violently ill, weakened on left side of body mostly from left hip down but now also shoulder, extreme disorientation, scary and nausea was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nervousness
Clinical narrative: Violently ill; weakened on left side of body mostly from left hip down but now also shoulder; Weekends on left side of body mostly from left hip down but now also shoulder; Feeling extreme disorientation; Extremely scary; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the right arm on 16Apr2021 at 09:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history (reported as perfectly healthy). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any other medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the right arm on 26Mar2021 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 21:00, 12 hours after vaccination, the patient experienced violently ill and could not get out of bed for 2 days and got better. On an unknown date in Apr2021 (also reported as week later), the patient experienced weakened on left side of body mostly from left hip down but now also shoulder, last night in the middle of the night, the patient woke up feeling extreme disorientation almost like she was in bed but was going to fall. The patient got out of bed crawled in all fours trying to get himself settled. The patient was able to get out of it slightly. It was extremely scary now patient felt the same left side weakness and nausea overall not feeling well at all. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events violently ill, weakened on left side of body mostly from left hip down but now also shoulder, extreme disorientation, scary and nausea was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Right arm injection site became swollen (golf ball size), warm and red, painful.; Right arm injection site became swollen (golf ball size), warm and red, painful.; Right arm injection site became swollen (golf ball size), warm and red, painful.; Right arm injection site became swollen (golf ball size), warm and red, painful.; As of 04/26/2021 still feeling discomfort.; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 08Apr2021 at 19:15 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included Sjogren's. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included daily multivitamin (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received naproxen sodium (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. On 09Apr2021 at 18:00, the patient's right arm injection site became swollen (golf ball size), warm and red, painful. As of 26Apr2021 still felt discomfort. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events right arm injection site became swollen (golf ball size), warm and red, painful and as of 26Apr2021 still felt discomfort was resolved with sequelae on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Limb discomfort, Vaccination site erythema, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Right arm injection site became swollen (golf ball size), warm and red, painful.; Right arm injection site became swollen (golf ball size), warm and red, painful.; Right arm injection site became swollen (golf ball size), warm and red, painful.; Right arm injection site became swollen (golf ball size), warm and red, painful.; As of 04/26/2021 still feeling discomfort.; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 08Apr2021 at 19:15 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included Sjogren's. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included daily multivitamin (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received naproxen sodium (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. On 09Apr2021 at 18:00, the patient's right arm injection site became swollen (golf ball size), warm and red, painful. As of 26Apr2021 still felt discomfort. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events right arm injection site became swollen (golf ball size), warm and red, painful and as of 26Apr2021 still felt discomfort was resolved with sequelae on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest discomfort, Dyspnoea, Lung disorder
Clinical narrative: Shortness of breath. It wasn't a heart attack. It was just as if "I" could not get a full breath.; As if "my" chest was tight/restricted from expanding all the way.; Beyond the common side-effects, which lasted for one week, I also had shortness of breath.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 29Mar2021 at 10:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient was not a smoker and didn't have any underlying health issues. The patient exercise frequently and eat healthy. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included methylphenidate hydrochloride (RITALIN); for an unknown indication from an unknown date and unknown if ongoing. On an unknown date in 2021, the patient experienced beyond the common side-effects, which lasted for one week. On 30Mar2021, the patient also experienced shortness of breath. It wasn't a heart attack. It was just as if he could not get a full breath. As if the patient's chest was tight/restricted from expanding all the way. The shortness of breath lasted for about two weeks. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chest tight/restricted from expanding all the way was recovering, while the clinical outcome of event shortness of breath/ could not get a full breath was recovered on an unknown date in Apr2021 and beyond the common side-effects, which lasted for one week resolved on unspecified date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Adverse drug reaction, Chest discomfort, Dyspnoea
Clinical narrative: Shortness of breath. It wasn't a heart attack. It was just as if "I" could not get a full breath.; As if "my" chest was tight/restricted from expanding all the way.; Beyond the common side-effects, which lasted for one week, I also had shortness of breath.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 29Mar2021 at 10:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient was not a smoker and didn't have any underlying health issues. The patient exercise frequently and eat healthy. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included methylphenidate hydrochloride (RITALIN); for an unknown indication from an unknown date and unknown if ongoing. On an unknown date in 2021, the patient experienced beyond the common side-effects, which lasted for one week. On 30Mar2021, the patient also experienced shortness of breath. It wasn't a heart attack. It was just as if he could not get a full breath. As if the patient's chest was tight/restricted from expanding all the way. The shortness of breath lasted for about two weeks. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chest tight/restricted from expanding all the way was recovering, while the clinical outcome of event shortness of breath/ could not get a full breath was recovered on an unknown date in Apr2021 and beyond the common side-effects, which lasted for one week resolved on unspecified date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Chest discomfort, Dyspnoea, Electrocardiogram, Heart rate increased
Clinical narrative: Panic attack like symptoms; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 14:30 (at the age of 19-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive concomitant medications. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) on an unknown date and experienced drug allergy. On 17Apr2021 at 03:30, the patient experienced panic attack like symptoms which were really bad that lead to an emergency room visit. The patient contacted his health care provider at the time of writing this and was told this was related to sympathomimetic amines. The event resulted in doctor or other healthcare professional office/clinic visit and emergency room/department visit or urgent care. Therapeutic measures were taken as a result of panic attack like symptoms which included treatment with unspecified medication to relieve anxiety. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event panic attack like symptoms was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypoaesthesia, Panic attack, Throat tightness, Tremor, X-ray
Clinical narrative: Panic attack like symptoms; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 14:30 (at the age of 19-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive concomitant medications. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) on an unknown date and experienced drug allergy. On 17Apr2021 at 03:30, the patient experienced panic attack like symptoms which were really bad that lead to an emergency room visit. The patient contacted his health care provider at the time of writing this and was told this was related to sympathomimetic amines. The event resulted in doctor or other healthcare professional office/clinic visit and emergency room/department visit or urgent care. Therapeutic measures were taken as a result of panic attack like symptoms which included treatment with unspecified medication to relieve anxiety. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event panic attack like symptoms was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest X-ray normal, Dizziness, Dyspnoea, Electrocardiogram normal, Metabolic function test
Clinical narrative: Panic attack like symptoms; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 14:30 (at the age of 19-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive concomitant medications. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) on an unknown date and experienced drug allergy. On 17Apr2021 at 03:30, the patient experienced panic attack like symptoms which were really bad that lead to an emergency room visit. The patient contacted his health care provider at the time of writing this and was told this was related to sympathomimetic amines. The event resulted in doctor or other healthcare professional office/clinic visit and emergency room/department visit or urgent care. Therapeutic measures were taken as a result of panic attack like symptoms which included treatment with unspecified medication to relieve anxiety. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event panic attack like symptoms was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Palpitations, Panic attack, Troponin
Clinical narrative: Panic attack like symptoms; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 14:30 (at the age of 19-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive concomitant medications. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) on an unknown date and experienced drug allergy. On 17Apr2021 at 03:30, the patient experienced panic attack like symptoms which were really bad that lead to an emergency room visit. The patient contacted his health care provider at the time of writing this and was told this was related to sympathomimetic amines. The event resulted in doctor or other healthcare professional office/clinic visit and emergency room/department visit or urgent care. Therapeutic measures were taken as a result of panic attack like symptoms which included treatment with unspecified medication to relieve anxiety. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event panic attack like symptoms was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Panic attack
Clinical narrative: Panic attack like symptoms; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 14:30 (at the age of 19-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive concomitant medications. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) on an unknown date and experienced drug allergy. On 17Apr2021 at 03:30, the patient experienced panic attack like symptoms which were really bad that lead to an emergency room visit. The patient contacted his health care provider at the time of writing this and was told this was related to sympathomimetic amines. The event resulted in doctor or other healthcare professional office/clinic visit and emergency room/department visit or urgent care. Therapeutic measures were taken as a result of panic attack like symptoms which included treatment with unspecified medication to relieve anxiety. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event panic attack like symptoms was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Eye irritation, Headache, Lacrimation increased, Ocular hyperaemia
Clinical narrative: Rash on face neck upper chest; Slight headache; Red itchy watery eyes; Red itchy watery eyes; Red itchy watery eyes; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 01:45 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included tofacitinib citrate (XELJANZ) from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 10:00, the patient experienced rash on face, neck, upper chest, slight headache and red itchy watery eyes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash on face, neck, upper chest, slight headache and red itchy watery eyes were resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: Rash on face neck upper chest; Slight headache; Red itchy watery eyes; Red itchy watery eyes; Red itchy watery eyes; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 01:45 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included tofacitinib citrate (XELJANZ) from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 10:00, the patient experienced rash on face, neck, upper chest, slight headache and red itchy watery eyes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash on face, neck, upper chest, slight headache and red itchy watery eyes were resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Eye pruritus, Headache, Lacrimation increased, Ocular hyperaemia, Rash
Clinical narrative: Rash on face neck upper chest; Slight headache; Red itchy watery eyes; Red itchy watery eyes; Red itchy watery eyes; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 01:45 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included tofacitinib citrate (XELJANZ) from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 10:00, the patient experienced rash on face, neck, upper chest, slight headache and red itchy watery eyes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash on face, neck, upper chest, slight headache and red itchy watery eyes were resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Hypoacusis, Tinnitus
Clinical narrative: Continuous buzzing in left ear; Headaches; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 13Apr2021 at 12:15 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history included gastroesophageal reflux disease (GERD) and known allergies to penicillin and sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received oseltamivir phosphate (TAMIFLU), famotidine (PEPCID) and acetylsalicylic acid (ASPIRIN); all for unknown indication from an unknown date and experienced drug allergy. On 15Apr2021 at 10:00, the patient experienced continuous buzzing in left ear and headaches. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events continuous buzzing in left ear and headaches were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Tinnitus
Clinical narrative: Continuous buzzing in left ear; Headaches; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 13Apr2021 at 12:15 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history included gastroesophageal reflux disease (GERD) and known allergies to penicillin and sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received oseltamivir phosphate (TAMIFLU), famotidine (PEPCID) and acetylsalicylic acid (ASPIRIN); all for unknown indication from an unknown date and experienced drug allergy. On 15Apr2021 at 10:00, the patient experienced continuous buzzing in left ear and headaches. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events continuous buzzing in left ear and headaches were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Left arm broke out into mild hives; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Apr2021 at 08:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies to some antibiotics. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medication within 2 weeks of vaccination. The patient previously received azithromycin (MANUFACTURER UNKNOWN) and experienced drug allergy. On 19Apr2021 at 19:30, 12 hours after vaccination, the patient experienced that her left arm broke out into mild hives. The hives cleared up by the next morning. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event hives was recovered on 20Apr2021.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Flushing, Paraesthesia, Pruritus, Rash erythematous
Clinical narrative: "My" neck began to itch, "I" rubbed it with "my" hands for a few minutes and then it started to tingle; "I"  went to look in the mirror and noticed that "my" neck and "my" face, were red.; "I" then began to feel a warm sensation on "my" arms and legs/ The warm, rushing sensation in "my" extremities lasted for about 5 minutes.; upon looking at them, "I" noticed red rashes around "my" elbows and knees/Around 2 hours later, the rashes were completely gone.; "My" neck began to itch, "I" rubbed it with "my" hands for a few minutes and then it started to tingle; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the right arm on 16Apr2021 at 09:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The medical history included fibromyalgia, anxiety, panic disorder, depression, kidney stones, allergy to nickel which caused dermatitis and allergy to contrast dye which caused anaphylaxis. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included escitalopram (MANUFACTURER UNKNOWN), vitamin b complex (VITAMIN B), ascorbic acid (VITAMIN C), vitamin d nos (VITAMIN D) and probiotic (unspecified); all for unknown indications from unknown dates and unknown if ongoing. On 20Apr2021, around 11:10, the patient's neck began to itch, she rubbed it with her hands for a few minutes and at 11:15, it started to tingle, she went to look in the mirror and noticed that her neck and her face were red. The patient then began to feel a warm sensation on her arms and legs and upon looked at them, she noticed red rashes around her elbows and knees. The warm, rushing sensation in her extremities lasted for about 5 minutes. The rashes were began to subside at that point. Around 2 hours later, the rashes were completely gone. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events neck began to itch, then it started to tingle, neck and face were red was unknown, while the clinical outcome of the event felt a warm sensation on arms and legs was resolved on 20Apr2021 at 11:20 and red rashes around elbows and knees was resolved on 20Apr2021.    No follow-up attempts are needed. No further information is expected.